Serum concentrations of Helicobacter pylori IgG and the virulence factor CagA in patients with ischaemic heart disease;Concentrations sériques d'IgG anti-Helicobacter pylori et facteur de virulence CagA chez les patients souffrant de cardiopathie ischémique

Eastern Mediterranean Health Journal

Volumn 16, Issue 10, 2010, Pages 1039-1044

  Jafarzadeh, A ^a   Esmaeeli Nadimi, A ^a   Nemati, M ^a   Tahmasbi, M ^a   Ahmadi, P ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY;

ACUTE HEART INFARCTION; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IRAN; ISCHEMIC HEART DISEASE; MALE; SEROPREVALENCE; UNSTABLE ANGINA PECTORIS;

EID: 78049352430     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2010.16.10.1039     Document Type: Article

References (30)

1. Beaglehole R, Magnus P. The search for new risk factors for coronary heart disease: occupational therapy for epidemiologists? International Journal of Epidemiology, 2002, 31:1117-1122.
2. Mahmoudi M, Curzen N, Gallagher PJ. Atherogenesis: the role of inflammation and infection. Histopathology, 2007, 50:535-546.
3. Ridker PM, Genest G, Libby P. Risk factors for atherosclerotic disease in Braunwald, Textbook of heart disease, 6th ed. Philadelphia, WB Saunders, 2001:1028-1031.
4. Jha HC, Prasad J, Mittal A. High immunoglobulin A seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker. Heart Vessels, 2008, 23(6):390-396.
5. Pellicano R et al. Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference? New Microbiology, 2002, 25(3):315-321.
6. Kinjo K et al. [Osaka Acute Coronary Insufficiency Study (OACIS) Group]. Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction. Circulation Journal, 2002, 66(9):805-810.
7. Vcev A et al. Helicobacter pylori infection and coronary artery disease. Collegium Antropologium, 2007, 31(3):757-760.
8. Nikolopoulou A et al. Common community infections and the risk for coronary artery disease and acute myocardial infarction: evidence for chronic over-expression of tumor necrosis factor alpha and vascular cells adhesion molecule-1. International journal of cardiology, 2008, 12,130(2):246-250.
9. Andreica V et al. The prevalence of anti-Helicobacter pylori antibodies in the patients with ischemic heart disease. Romanian Journal of Internal Medicine, 2004, 42(1):183-189.
10. Miyazaki M et al. Is Helicobacter pylori infection a risk factor for acute coronary syndromes? Journal of Infection, 2006, 52(2):86-91.
11. Chaudhury A et al. Seroprevalence of IgG antibodies to Chlamydia pneumoniae and Helicobacter pylori among coronary heart disease patients and normal individuals in South Indian population. Indian Journal of Pathology and Microbiology,N 2004, 47(3):433-434.
12. Kanbay M et al. Helicobacter pylori seroprevalence in patients with coronary artery disease. Digstive Diseases and Sciences, 2005, 50(11):2071-2074.
13. Sotiropoulos A et al. Seropositivity to Chlamydia pneumoniae or Helicobacter pylori and coronary artery disease. International Journal of Cardiology, 2006, 109(3):420-421.
14. Lenzi C et al. H. pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease. World Journal of Gastroenterology. 2006, 12(48):7815-7820.
15. Figueiredo C, Marchado JC, Yamaoka Y. Pathogenesis of Helicobacter pylori Infection. Helicobacter, 2005,10(Suppl. 1):14-20.
16. Jimenze F et al. Seroprevalence of Helicobacter pylori anti- CagA antibodies and its relationship with epidemiologic factors in Santa Fe. Acta Gastroenterologica Latinoamericana, 2004, 34:16-20.
17. Jafarzadeh A, Rezayati MT, Nemati M. Specific serum immunoglobulin G to H. pylori and CagA in healthy children and adults (south-east of Iran). World Journal of Gastroenterology. 2007, 13:3117-121.
18. Manolakis A, Kapsoritakis AN, Potamianos SP. A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease. Helicobacter, 2007, 12:287-297.
19. Reszka E et al. Detection of infectious agents by polymerase chain reaction in human aortic wall. Cardiovascular Pathology, 2008, 17(5):297-302.
20. Zhang S et al. Cytotoxin-associated gene-A-seropositive virulent strains of Helicobacter pylori and atherosclerotic diseases: a systematic review. Chinese Medical Journal, 2008, 121(10):946-951.
21. Koenig W et al. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. Circulation, 1999, 100(23):2326-2331.
22. Chmiela M et al. A link between Helicobacter pylori and/or Chlamydia spp. infections and atherosclerosis. FEMS Immunology and Medical Microbiology, 2003, 36(3):187-192.
23. Singh RK et al. Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease. Heart, 2002, 88(1):43-46.
24. Azuma T. Helicobacter pylori CagA protein variation associated with gastric cancer in Asia. Journal of Gastroenterology, 2004, 39(2):97-103.
25. Basso D, Plebani M. H. pylori infection: bacterial virulence factors and cytokine gene polymorphisms as determinants of infection outcome. Critical Reviews in Clinical Laboratory Sciences, 2004, 41:313-337
26. Jafarzadeh A, Hasanshahi GH, Nemati M. Serum levels of highsensitivity C-reactive protein (hs-CRP) in Helicobacter pyloriinfected peptic ulcer patients and its association with bacterial CagA virulence factor. Digstive Diseases and Sciences, 2009, 54(12):2612-2616.
27. Jafarzadeh A, Salari M. Seroprevalence of anti-Helicobacter pylori and anti-CagA antibodies in peptic ulcer and healthy subjects in the city of Rafsanjan. Journal of Research in Medical Sciences, 2006, 11:285-291.
28. Cammarota G et al. Is there mimicry between arteriosclerotic lesions and H. pylori antigens? Clinical Biochemistry. 2000, 33:419-421.
29. Franceschi F et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation, 2002, 106:430-434.
30. Steptoe A et al. Socioeconomic status, pathogen burden and cardiovascular disease risk. Heart, 2007, 93(12):1567-1570.